Simulations for designing and interpreting intervention trials in infectious diseases
M. Elizabeth Halloran(Emory University), Marc Lipsitch(Harvard University), Steven E. Bellan(University of Georgia), Berk Özler(World Bank Group), Eric Lofgren(Washington State University), Kari Auranen(University of Turku), Justin Lessler(Johns Hopkins University), James P. Hughes(University of Washington), Alessandro Vespignani(Institute for Scientific Interchange), Nicole E. Basta(University of Minnesota), Sarah Baird(Milken Institute), Emilia Vynnycky(Public Health England), Ben S. Cooper(Health Protection Agency), Ira M. Longini(University of Washington), Ron Brookmeyer(Johns Hopkins University), Thomas A. Smith(Swiss Tropical and Public Health Institute), Victor DeGruttola(Harvard University), Jukka-Pekka Onnela(Harvard University), George R. Seage(Harvard University)
Cited by 80
Related Papers
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
|Neurology|1989|4.1k
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease
|Neurology|1997|966
Decontamination of the Digestive Tract and Oropharynx in ICU Patients
|New England Journal of Medicine|2008|823
Cash or Condition? Evidence from a Cash Transfer Experiment
|The Quarterly Journal of Economics|2011|820